You are here

Modified Nanoparticles for Lipophilic Toxin Sequestration

Award Information
Agency: Department of Defense
Branch: Air Force
Contract: FA9550-11-C-0092
Agency Tracking Number: F10B-T24-0250
Amount: $100,000.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: AF10-BT24
Solicitation Number: 2010.B
Solicitation Year: 2010
Award Year: 2011
Award Start Date (Proposal Award Date): 2011-09-01
Award End Date (Contract End Date): N/A
Small Business Information
1801 Maple Avenue, Suite 4301, Evanston, IL, -
DUNS: 831421958
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Weston Daniel
 Research Scientist
 (847) 467-2874
Business Contact
 Percy Crocker
Title: VP Commercial Development
Phone: (847) 467-2874
Research Institution
 Northwestern University
 C. S Thaxton
 300 E Superior Street, 16-703
Dept of Urology, Tarry Bldg
Chicago, IL, 60611-
 (312) 908-8145
 Nonprofit college or university
ABSTRACT: Mycotoxins are a class of weaponizable toxic secondary metabolites of molds and fungi. No treatments exist for exposure to these lipophilic poisons. AuraSense proposes to use lipid and protein modified gold nanoparticles to develop constructs for the sequestration of toxic lipophilic molecules. Nanoparticles are ideal materials for development of such a system, as they are able to be finely tuned in terms of their size, molecular composition, surface charge, and interfacial properties. In addition, we have demonstrated in preliminary work that they are nontoxic, and have a proven ability to avidly bind lipophilic molecules. Due to the difficulty of working with mycotoxins, cholesterol will be used as a model system to demonstrate sequestration from cell membranes. BENEFIT: AuraSense"s nanoparticle constructs have great potential as effective agents for transporting lipophilic toxins, such as mycotoxins, safely out of the body. AuraSense nanoparticle technology has been developed in numerous proof-of-concept applications and has been the subject of consistent commercial interest to date. This platform stands to significantly advance defense alternatives in combating lipophilic toxins. While broadly applicable in a number of therapeutic areas, AuraSense"s nanoparticle platforms are highly relevant to the Biodefense market.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government